Skip to Main Content

Sunil Parikh, MD, MPH

Associate Professor of Epidemiology (Microbial Diseases) and of Medicine (Infectious Diseases)

Contact Information

Sunil Parikh, MD, MPH

Lab Location

Office Location

Mailing Address

  • Epidemiology of Microbial Diseases

    60 College Street, P.O. Box 208322

    New Haven, CA, 06520

    United States

Research Summary

Dr. Parikh focuses upon several aspects of malaria in sub-Saharan Africa, including studies focused on optimizing treatment regimens, novel chemoprevention strategies, drug resistance emergence and spread, and parasite dynamics. Current projects include: (1) understanding host factors affecting response to artemisinin-based antimalarial therapies using a combination of individual and population-based pharmacologic approaches to inform treatment guidelines (Uganda and Burkina Faso); 2) novel use of a endectocides to reduce malaria transmission (Burkina Faso); and 3) characterizing the epidemiology of antimalarial drug resistance and non-falciparum species in sub-Saharan Africa (Burkina Faso and Cameroon). Dr. Parikh has ongoing projects in several African countries, which span observational, interventional, and cross-sectional designs.

Specialized Terms: Translation research in malaria; Pharmacology of antimalarials; HIV-malaria co-infection; Host response to malaria infection; Innate immunity to malaria

Extensive Research Description

1) Antimalarial Therapy in the context of pregnancy, growth/development, and HIV co-infection in Uganda

Major Goal: To assess the pharmacokinetics and pharmacodynamics of artemisinin-combination therapies and their impact upon efficacy and drug resistance in vulnerable populations. We are conducting a randomized controlled trial of two different antimalarial regimens in children with and without HIV in Uganda.

2) Use of novel approaches to preventing malaria in Burkina Faso

Major Goal: We are conducting a cluster-randomized trial of a novel chemopreventive approach in Burkina Faso

3) Studying parasite dynamics and the emergence and spread of drug resistance in parasites in Burkina Faso

4) Characterizing the epidemiology of non-falciparum species in Cameroon and Uganda.

5) COVID-19 in long-term care facilities in Connecticut


Research Interests

Africa; Burkina Faso; Cameroon; Developing Countries; Diagnosis; Epidemiology; Malaria; Parasitic Diseases; Public Health; Uganda; Global Health; Infectious Disease Medicine

Public Health Interests

Clinical Trials; Epidemiology Methods; Genetics, Genomics, Epigenetics; Global Health; Immunology; Infectious Diseases; Malaria; Parasitology; Reproduction; Child/Adolescent Health; COVID-19

Selected Publications